Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 5 of 5
Full-Text Articles in Medicine and Health Sciences
Understanding The Role Of Promotora In A Latino Diabetes Education Program, Lynn Deitrick, Hannah Paxton, Alicia Rivera, Eric Gertner, Nyann Biery, Abby Letcher, Lissette Lahoz, Edgar Maldonado, Debbie Salas-Lopez
Understanding The Role Of Promotora In A Latino Diabetes Education Program, Lynn Deitrick, Hannah Paxton, Alicia Rivera, Eric Gertner, Nyann Biery, Abby Letcher, Lissette Lahoz, Edgar Maldonado, Debbie Salas-Lopez
Debbie Salas-Lopez MD, MPH
No abstract provided.
Comparison Of Insulin Infusion Protocols Targeting 110-140 Mg/Dl In Patients After Cardiac Surgery., Vasudev Magaji, Shriddha Nayak, Amy Donihi, Lauren Willard, Srinivasa Jampana, Parachur Nivedita, Raymond Eder, Jann Johnston, Mary Korytkowski
Comparison Of Insulin Infusion Protocols Targeting 110-140 Mg/Dl In Patients After Cardiac Surgery., Vasudev Magaji, Shriddha Nayak, Amy Donihi, Lauren Willard, Srinivasa Jampana, Parachur Nivedita, Raymond Eder, Jann Johnston, Mary Korytkowski
Vasudev G Magaji MD, MS
BACKGROUND: Continuous intravenous insulin infusion (CII) following coronary artery bypass graft (CABG) surgery reduces postoperative complications and hospitalization duration. Because of limited data evaluating outcomes of CII with revised glycemic targets (110-140 mg/dL) in cardiac surgery, this study compared efficacy and safety of two different CII protocols having revised targets. SUBJECTS AND METHODS: This is a retrospective study comparing two different protocols between August 2009 and March 2010. Protocol 1 consists of four algorithms, and Protocol 2 is a table to adjust CII. Blood glucose (BG) and CII rates were recorded for 48 h postoperatively or CII discontinuation. Efficacy was …
Efficacy And Safety Of Continuous Insulin Infusion Protocols With Glycemic Targets Of 110-140 Mg/Dl In Patients With And Without Diabetes Following Cardiac Surgery, Shriddha Nayak, Vasudev Magaji, Amy Donihi, Lauren Willard, Srinivasa Jampana, Parachur Nivedita, Raymond Eder, Jann Johnston, Mary Korytkowski
Efficacy And Safety Of Continuous Insulin Infusion Protocols With Glycemic Targets Of 110-140 Mg/Dl In Patients With And Without Diabetes Following Cardiac Surgery, Shriddha Nayak, Vasudev Magaji, Amy Donihi, Lauren Willard, Srinivasa Jampana, Parachur Nivedita, Raymond Eder, Jann Johnston, Mary Korytkowski
Vasudev G Magaji MD, MS
No abstract provided.
Inpatient Management Of Hyerglycemia And Diabetes, Vasudev Magaji, Jann Johnston
Inpatient Management Of Hyerglycemia And Diabetes, Vasudev Magaji, Jann Johnston
Vasudev G Magaji MD, MS
No abstract provided.
Short Term Unblinded Continuous Glucose Monitoring For Long Term Glucose Control, Vasudev Magaji, Adam Akers, Jann Johnston
Short Term Unblinded Continuous Glucose Monitoring For Long Term Glucose Control, Vasudev Magaji, Adam Akers, Jann Johnston
Vasudev G Magaji MD, MS
No abstract provided.